ArticleBlood advances2025

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.

Oluwatobi Odetola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.